We serve Chemical Name:(r)-4-phenyloxazolidine-2,5-dione CAS:3412-49-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(r)-4-phenyloxazolidine-2,5-dione
CAS.NO:3412-49-5
Synonyms:N-carboxy-(R)-phenylglycine anhydride;(R)-4-phenyl-oxazolidine-2,5-dione;(R)-N-carboxyphenylglycine anhydride;N-Carboxy-D-phenylglycinanhydrid;D-3-Methyl-4-phenyl-oxazolidin-dion-(2,5);D-Phenylglycine-N-carboxyanhydride
Molecular Formula:C9H7NO3
Molecular Weight:177.15700
HS Code:2934999090
Physical and Chemical Properties:
Melting point:123-126ºC
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:55.40000
Exact Mass:177.04300
LogP:1.32290
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-carboxy-(R)-phenylglycine anhydride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,D-Phenylglycine-N-carboxyanhydride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,D-Phenylglycine-N-carboxyanhydride Use and application,N-carboxy-(R)-phenylglycine anhydride technical grade,usp/ep/jp grade.
Related News: By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. (r)-4-phenyloxazolidine-2,5-dione manufacturer By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. (r)-4-phenyloxazolidine-2,5-dione supplier With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines. (r)-4-phenyloxazolidine-2,5-dione vendor The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. (r)-4-phenyloxazolidine-2,5-dione factory With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.
